Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period
Rare Disease Market accounted for US$ 161.4 billion in 2020 and is estimated to be US$ 547.5 billion by 2030 and is anticipated to register a CAGR of 13.1%. Rare disease is any disease that affects a small percentage of the total population. In some parts of the world, an orphan disease is a rare disease whose rarity supports that there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions for creating and selling such treatments. Orphan drugs are ones in thousand so these drugs are created and sold boosting the market. The report " Global Rare disease Market, By Drug Type (Biologics and Non-biologics),By Route of Administration (Oral and Injectable), By Phase (Preclinical, Phase1, Phase2, Phase3 and Phase4), By Therapeutic Area (Infectious disease, Neurological, Alimentary/Metabolic, Cancer, Blood & Clotting and Others), By Patients (Neonatal, Pediatric,